SCMR Product Specific and Non-Specific Product Survey Question Title * 1. If you would like to be considered for the drawing of a complimentary registration for 2027, please enter your name and email below. If you do not want to be considered, we do not need your information. Question Title * 2. E-mail address As part of this interactive audience survey, select conference sponsors have contributed product-specific or non-product-specific questions. Your responses will help sponsors better understand attendee interests and needs, and aggregated results may be shared with participating sponsors. Thank you for taking a moment to share your insights. Question Title * 3. Which MR vendors do you use for CMR at your site? Canon GE HealthCare Philips Siemens Healthineers United Imaging Other Question Title * 4. Which change do you expect once a regulatory-cleared product solution for dual-sequence myocardial quantitative perfusion is available ? My site will start new stress CMR program My site’s stress CMR volume is going to remain more or less the same My site’s stress CMR volume is going to increase significantly My site’s stress CMR volume is going to decrease significantly Not sure Question Title * 5. How important should it be for the SCMR to include an objective, data-driven educational session on evaluating CMR post-processing software as part of its Annual Meeting? Not important Low importance — interesting but optional Moderately important — useful but not essential Very important — it would significantly enhance the meeting's value Essential — this should be a core educational offering Not important Low importance — interesting but optional Moderately important — useful but not essential Very important — it would significantly enhance the meeting's value Essential — this should be a core educational offering Question Title * 6. If you were starting a new CMR practice and could choose your post-processing software independently—without constraints related to group consensus, IT implementation effort, or cost—what would you most likely do? Definitely choose my current software Probably choose my current software Seriously consider switching to a different solution Actively look to switch to a different solution Not sure Question Title * 7. What would be the most meaningful impact of using experienced external technologists for remote CMR scanning at your facility or across your network? Enabling CMR availability at community or satellite sites Reducing patient wait times or clearing backlog Increasing CMR volume at the main site Improving scan quality and consistency across locations Reducing reliance on in-house CMR experts I do not see a meaningful impact for my facility or network Question Title * 8. What is the biggest barrier to adopting remote CMR scanning services that use experienced external technologists to support or run exams across your sites? IT or cybersecurity concerns Regulatory, licensing, or credentialing requirements Workflow integration or change management Cost or reimbursement uncertainty Lack of internal expertise to support implementation Concerns about the consistency or quality of remote scanning Question Title * 9. What would you consider your biggest pain point when reading a cardiac MRI study? 2D measurements Flow measurements Volumetric measurements Reporting Accurate & Complete Billing Question Title * 10. When considering MRI-compatible 3D mapping technology, which of the following data points would provide the most value if they were more accessible or better integrated than they are today? (Select all that apply) Functional & Volumetric Analysis: (e.g., Ejection fraction, ventricular volumes, wall motion, or strain analysis) Hemodynamics & Advanced Flow: (e.g., 4D flow velocity/direction, pressure gradients, fractional flow reserve, or wall shear stress) Advanced Tissue Characterization: (e.g., Parametric T1/T2 mapping, extracellular volume (ECV) fraction, or fibrosis quantification). Vascular & Plaque Morphology: (e.g., Calcium scoring, lipid-rich necrotic core identification, or plaque stability/composition) Electrophysiological Integration: (e.g., Late Gadolinium Enhancement (LGE) integration for substrate mapping) Question Title * 11. In your cardiac MR practice, which post processing module, if significantly improved in the next 12 months, would have the biggest positive impact on patient care and workflow at your center? Functional assessment 2D and 4D Flow quantification Perfusion quantification (qualitative or quantitative) Deformation analysis (strain / feature tracking) Tissue characterization – parametric mapping (T1/T2/T2*; ECV) Tissue characterization – LGE (infarct quantification & interpretation) Question Title * 12. What is your biggest challenge when interpreting cardiac MRI data today? Inter-observer variability Time pressure/Reporting fatigue Complex cases (HF / cardiomyopathies / myocarditis) Data overload Access to specialist expertise Question Title * 13. In our center, the reason to acquire 4D Flow data is based on patients with: Any MRI scan Valvular disease Cardiomyopathy Congenital disease (Adult and/or Pediatric) Aortic disease, None of the above, we don't acquire 4D flow data Question Title * 14. How confident do you feel in applying European and American guidelines to your daily CMR practice? Not at all Confident Not Confident Neutral Confident Very Confident Not at all Confident Not Confident Neutral Confident Very Confident Question Title * 15. Which aspect of establishing a cardiac MR imaging service do you find most challenging or crucial? Collaboration between cardiologists and technologists Implementing key components for a successful service Ensuring continuous education for the team Managing and optimizing AI tools Other Question Title * 16. How satisfied are you with the availability of educational resources for CMR in your current professional development? Very dissatisfied Satisfied Neutral Satisfied Very satisfied Very dissatisfied Satisfied Neutral Satisfied Very satisfied Question Title * 17. In addition to CMR studies, what other cardiovascular imaging procedures are you responsible for interpreting? Cardiac CT / CCTA Echocardiography Nuclear Cardiology (SPECT/PET) Interventional Imaging (Cath lab/Angio) None (I interpret CMR only) Question Title * 18. What application do you use for reporting your CMR study interpretations? PowerScribe M*Modal Fluency Native EHR Reporting Native PACS Reporting Structured Reporting within Post-Processing Software Other Question Title * 19. How frequently do you need to look at a patient’s prior Echocardiogram when interpreting their current CMR study? Every study >50% of the time 25-50% of the time Question Title * 20. Which scanners do you use for CMR in your institution? Mark ALL relevant answers. Canon 1.5 Canon 3T GE 1.5T GE 3T Philips 1.5T Philips 3T Siemens 1.5T Siemens 3T United Imaging 1.5T United imaging 3T Question Title * 21. How do you see the role of low-field? I’m skeptical It may be interesting in a research setting I’d like to try it I believe it holds great potential for routine CMR examinations Question Title * 22. Please assess utilization of MR angiography at your institution in the next few (< 3) years. It will not increase due to strong competition from other modalities, e.g., CT There will be increased usage of MRI for vessel wall imaging Contrast-enhanced MR angiography (both Gd- and other ion-based contrast agents) volume will increase There will be more non-contrast MR angiography procedures performed at our institution Done